AlphaTON Capital Corp. (ATON) NASDAQ
0.28
-0.0305(-9.87%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.28
-0.0305(-9.87%)
Currency In USD
Address
Clarence Thomas Building
Road Town, VG1110
United States of America (the)
Phone
302 219 5556
Sector
Financial Services
Industry
Asset Management
Employees
4
First IPO Date
January 02, 2002
| Name | Title | Pay | Year Born |
| Peter Molloy | Chief Executive Officer of Cyncado Therapeutics Inc. | 0 | N/A |
| Brittany Kaiser | Chief Executive Officer & Director | 0 | 1989 |
| Robert A. Kramer | Chief Scientific Officer | 119,250 | 1952 |
| Wesley Allen Levitt | Chief Financial Officer | 518,205 | 1988 |
| Adam Melero | Controller | 0 | N/A |
| William De'Ath | Chief Partnership Officer | 0 | N/A |
| Fiorenzo A. Villani | Executive Chairman & Chief Investment Officer | 0 | 1971 |
| Logan Ryan Golema | Chief Technology Officer | 0 | N/A |
AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.